SACK1B and ovarian carcinoma: On the other hand, it has been very recently reported that ovarian cancer patients with low FAM83B levels have shorter survival time and show cisplatin resistance8, while high expression of FAM83B correlates with prolonged progression-free interval in triple negative breast cancer20.